LakeShore Biopharma (LSB) said Tuesday the Nasdaq Stock Market notified the company Oct. 21 that it was in compliance with the exchange's minimum bid price requirement for continued listing.
The company regained compliance after the closing bid price of its shares was at $1 each or higher for 11 consecutive business days through Oct. 18.
LakeShore shares were up 3.5% in recent trading.
Price: 2.97, Change: +0.10, Percent Change: +3.48